BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:U.S. CDMRP – Autism Research Program | Research Funding
DTSTART;VALUE=DATE:20220523
DTSTAMP:20260413T220658Z
UID:eb57001488504660ea4a429d770f00cf558acc94584d8b9039334b16
CATEGORIES:Call for proposal
DESCRIPTION:Aim: Through the Congressionally Directed Medical Research Pro
 gram (CDMRP)\, the Department of Defense is announcing the Autism Research
  Program (ARP) Awards. Three award programs are available:\n \n\n	The FY2
 2 ARP Idea Development Award mechanism supports the development of innovat
 ive\, high-risk/high-reward research that could lead to critical discoveri
 es or major advancements that will accelerate progress in improving outcom
 es for individuals with ASD. This award mechanism is designed to support i
 nnovative ideas with the potential to yield impactful data and new avenues
  of investigation.\n	 \n	The FY22 ARP Career Development Award supports e
 arly-career\, independent investigators and/or the transition of establish
 ed investigators from other research fields to conduct innovative\, high-i
 mpact ideas or early-phase\, proof-of-principle clinical trials with the p
 otential to have a major impact on ASD.. \n\n\nAll applications for ARP f
 unding are strongly encouraged to address at least one of the Areas of Emp
 hasis as directed by Congress and have direct relevance to military health
 . The FY22 ARP Topic Areas are listed at the end of this announcement.\n\n
 Funding:       Idea Development Award – max. $550’000\n     
                    Career Development Award – max. $55
 0’000\n\nDuration:      Idea Development Award – 3 years\n    
                     Career Development Award – 3 year
 s\n\nEligibility: Applicants from international organizations or instituti
 ons are eligible to apply\, and there are no citizenship restrictions. All
  investigators at or above the level of assistant professor (or equivalent
 ) are eligible.\n\nHow to Apply: Pre-applications are submitted through th
 e eBRAP platform. They should contain contact information\, a pre-proposal
  narrative\, and a list of collaborators and key personnel as suggested on
  the platform. Full applications will be made via a Grants.gov workspace. 
 Full application packages can be downloaded from Grants.gov at any time.\n
 \nPre-Application Deadline: May 23\, 2022\, 5:00 p.m. Eastern time (ET)\nF
 ull Application Deadline: August 18\, 2022\n\nGrants.gov Funding Opportuni
 ty Numbers:\n\n\n	Idea Development Award –  W81XWH-22-ARP-IDA\n	Career 
 Development Award – W81XWH-22-ARP-CDA\n\n\nFurther information\n\n\n	To 
 see the program announcement\, navigate to the search page on Grants.gov a
 nd search for the Opportunity Numbers given above\n	For questions about th
 e eBRAP or Grants.gov platforms\, contact the Research Office.\n\n\nAreas 
 of Emphasis: \n\n\n	Tests of implementation strategies to increase use of 
 evidence-based practices\n\n\n\n	Assessment of novel therapeutics using va
 lid preclinical models\n	Mechanisms of heterogeneous clinical expression o
 f ASD\n	Environmental risk factors\n	Improve diagnosis across the life spa
 n\n	Factors promoting success in key transitions to independence for indiv
 iduals living with ASD\n	Development of healthcare provider-focused traini
 ng or tools to improve healthcare delivery for individuals with ASD across
  the life span and the continuum of care (i.e.\, primary care\, urgent/eme
 rgent care\, and disaster relief)\n\n\n\n	Cultural\, socioeconomic\, and g
 ender factors in diagnosis\, treatment efficacy\, delivery\, and access to
  services\n	Mechanisms underlying sex differences in ASD (i.e.\, prevalenc
 e\, biological mechanisms\, phenotypic expression\, core and comorbid synd
 rome expression and outcomes\, developmental trajectories\, diagnosis\, an
 d treatment response)\n	Mechanisms underlying conditions co-occurring with
  ASD (e.g.\, sleep disturbances\, gastrointestinal issues\, inflammation\,
  aggression\, depression\, anxiety\, attention deficit\, and seizures)\n	F
 actors impacting quality of life during geographic relocation\, such as mi
 litary permanent change of station\n	Long-term treatment outcomes from pre
 vious clinical trials for ASD core symptoms or to alleviate co-occurring c
 onditions\n	Create tools and strategies to increase the speed with which e
 vidence-based practices are deployed in community-based settings\n
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR